Case 7-2005: A 59-year-old woman with an incidentally discovered adrenal nodule

New England Journal of Medicine

Volumn 352, Issue 10, 2005, Pages 1025-1032

  Dluhy, Robert G ^a,c   Maher, Michael M ^b,c   Wu, Chin Lee ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CONTRAST MEDIUM; DEXAMETHASONE; DOXAZOSIN; HYDROXYCHLOROQUINE; IODOCHOLESTEROL; LISINOPRIL; NIFEDIPINE; DIAGNOSTIC AGENT; HYDROCORTISONE;

ADRENAL CORTEX ADENOMA; ADRENAL SCINTISCANNING; ADRENAL TUMOR; ADULT; ARTHRITIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DYSURIA; ESCHERICHIA COLI; FEMALE; HUMAN; HYPERTENSION; INCIDENTAL FINDING; NEUROLOGIC EXAMINATION; OBESITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PYURIA; REVIEW; URINARY TRACT INFECTION; ADRENAL CORTEX TUMOR; ADRENAL DISEASE; ADRENAL GLAND; ARTICLE; BLOOD; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; MICTURITION DISORDER; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING;

19-IODOCHOLESTEROL; ADRENAL CORTEX NEOPLASMS; ADRENAL GLAND DISEASES; ADRENAL GLANDS; ADRENOCORTICAL ADENOMA; CUSHING SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDROCORTISONE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; URINATION DISORDERS;

EID: 14844299805     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcpc059002     Document Type: Review

References (22)

1. Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 2003;138:424-9.
2. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000;85:637-44.
3. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 1999;84:520-6.
4. Dluhy RG, Lawrence JE, Williams GH. Primary mineralocorticoid excess states. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams textbook of endocrinology. 10th ed. Philadelphia: WB. Saunders, 2003:573-6.
5. Raff H, Findling JW. A physiologic approach to diagnosis of the Gushing syndrome. Ann Intern Med 2003;138:980-91.
6. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 1992; 75:826-32.
7. Rossi R, Tauchmanova L, Luciano A, et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000;85:1440-8.
8. Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalssinos N. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clin Endocrinol (Oxf) 1998;49:165-71.
9. Giraldi FP, Invitti C, Cavagnini F. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal. Clin Endocrinol (Oxf) 2001;54:601-7.
10. Lacroix A, Ndiaye N, Tremblay J, Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 2001;22:75-110.
11. Mircescu H, Jilwan J, N'Diaye N, et al. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? J Clin Endocrinol Metab 2000;85:3531-6.
12. Lacroix A, Boité E, Tremblay J, et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion - a new cause of Cushing's syndrome. N Engl J Med 1992; 327:974-80.
13. N'Diaye N, Hamet P, Tremblay J, Bourin J, Gaboury L, Lacroix A. Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing's syndrome. J Clin Endocrinol Metab 1999;84:2616-22.
14. Lacroix A, Hamet P, Boutin J-M. Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. N Engl J Med 1999;341:1577-81.
15. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. Propranolol therapy for ectopic β-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 1997; 337:1429-34.
16. Croughs RJ, Zelissen PM, van Vroonhoven TJ, et al. GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH. Clin Endocrinol (Oxf) 2000;52:235-40.
17. Barzon L, Scaroni C, Sonino N, et al. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab 1998;83:55-62.
18. Gross MD, Shapiro B, Francis IR, et al. Scintigraphic evaluation of clinically silent adrenal masses. J Nucl Med 1994;35:1145-52.
19. Adrenal cortical adenoma. In: Lack EE. Tumors of the adrenal gland and extraadrenal paraganglia. 3rd series. Fascicle 19. Washington, D.C.: Armed Forces Institute of Pathology, 1997:91-122.
20. Adrenal cortical carcinoma. In: Lack EE. Tumors of the adrenal gland and extraadrenal paraganglia. 3rd series. Fascicle 19. Washington, D.C.: Armed Forces Institute of Pathology, 1997:123-52.
21. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984;8:163-9.
22. Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 1989;13:202-6.